NDTVCenter·
Emcure Pharmaceuticals Share Price Hits 10% Upper Circuit To Touch 52-Week High; Should You Buy?
Emcure Pharmaceuticals reported its earnings for the September quarter on November 3, with double-digit revenue growth and operating profit.
Read at NDTV →




